Provided by Tiger Fintech (Singapore) Pte. Ltd.

ChromaDex

7.87
+0.0000
Volume:- -
Turnover:4.35M
Market Cap:613.21M
PE:71.55
High:7.87
Open:7.87
Low:7.87
Close:7.87
Loading ...

ChromaDex Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Mar

BRIEF-Chromadex announces name change and new ticker symbol effective March 19

Reuters
·
13 Mar

Chromadex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "Nage" Effective March 19, 2025

THOMSON REUTERS
·
13 Mar

ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025

Business Wire
·
13 Mar

ChromaDex to Present at the 37th Annual Roth Conference

Business Wire
·
12 Mar

ChromaDex Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
10 Mar

ChromaDex price target raised to $11 from $8 at H.C. Wainwright

TIPRANKS
·
10 Mar

Discovering US Market's Hidden Gems with Strong Financials

Simply Wall St.
·
06 Mar

ChromaDex Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
06 Mar

ChromaDex Is Maintained at Buy by Ladenburg Thalmann

Dow Jones
·
06 Mar

ChromaDex Shares Rise After 4Q Earnings Beat

Dow Jones
·
06 Mar

Q4 2024 Chromadex Corp Earnings Call

Thomson Reuters StreetEvents
·
06 Mar

ChromaDex Up Nearly 50%, On Track for Highest Close Since September 2021 -- Data Talk

Dow Jones
·
05 Mar

Chromadex (CDXC) Gets a Buy from Roth MKM

TIPRANKS
·
05 Mar

ChromaDex price target raised to $8.10 from $6.80 at Ladenburg

TIPRANKS
·
05 Mar

ChromaDex Corp (CDXC) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advances

GuruFocus.com
·
05 Mar

Chromadex Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
05 Mar

ChromaDex (CDXC) Q4 Earnings and Revenues Surpass Estimates

Zacks
·
05 Mar

Chromadex Reports Strong Q4 2024 Financial Growth

TIPRANKS
·
05 Mar

ChromaDex: Q4 Earnings Snapshot

Associated Press Finance
·
05 Mar